Neuropsychological and Behavioral Testing in Young Patients With Cancer

Status: Recruiting
Phase: N/A
Diagnosis: Pediatric Brain Tumor
NCT ID: NCT00772200 (View complete trial on
DFCI Protocol ID: 08-363


This clinical trial is studying neuropsychological and behavioral testing in young patients with cancer. Collecting information over time from a series of tests may help doctors develop effective tests to measure neuropsychological and behavioral function in young patients with cancer.


Conducting Institutions:
Dana-Farber Cancer Institute, Children's Hospital Boston, Massachusetts General Hospital

Overall PI:
Peter Manley, MD, Dana-Farber Cancer Institute

Site-responsible Investigators:

Dana-Farber Cancer Institute: Childrens Hospital Pediatric Clinical Translation Investigation Program CTIP,

Eligibility Criteria

DISEASE CHARACTERISTICS: - Histologically confirmed diagnosis of medulloblastoma or supratentorial primitive neuroectodermal tumor (PNET) - Must be currently enrolled on COG-ACNS0331 or COG-ACNS0332 that aims to examine neuropsychological, social, emotional, and/or behavioral functioning PATIENT CHARACTERISTICS: - Must have receptive and expressive English language skills - No history of pre-existing neurodevelopmental disorder (e.g., traumatic brain injury, mental retardation, or Down syndrome) prior to diagnosis of childhood cancer - No history of birth weight < 1,500 g (associated with neuropsychological deficits) PRIOR CONCURRENT THERAPY: - See Disease Characteristics
  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms
  • Make an Appointment

    • For adults:
      877-442-3324 (877-442-DFCI)

    • Quick access:
      Appointments as soon as the next day for new adult patients

    • For children:
      888-733-4662 (888-PEDI-ONC)

    • Make Appointment Online